Patient Educational Q & A
Antidepressants and Chronic Pain
3/30/18
What are the benefits of using central neuromodulators (anti-depressant, anti-anxiety, anti-psychotic agents) to treat GI disorders.
- About
- Communication Programs
- Award for Communication & Patient Centered Care in DGBI
- Rome – DrossmanCare Communication Collaboration
- Gut Feelings Book Series
- Educational Videos on Communication
- Visiting Scholar Program
- Rome – AGA Communication Conference Videos
- Educational Resources on Communication Skills
- Research
- Working Teams
- Active Working Teams (2020-2023)
- Completed Working Teams
- Food and Diet in DGBI Working Team
- Brain-Gut Psychotherapies Working Team
- Communications Working Team
- Neuromodulators for FGIDs
- Post-infection IBS
- Brain Imaging in DGBI
- Asian Working Team for FGIDs
- Food & FGIDs Working Team
- Role of Intestinal Flora in FGIDs
- Multinational Cross-Cultural Research
- Primary Care Committee
- Brain Imaging Working Team
- Outcomes/Endpoints in Pharmaceutical Clinical Trials
- Rome Severity Committee
- Rome Working Teams Publications
- GastroPsych
- Pediatrics
- Rome IV/V & Criteria
- Resources
© COPYRIGHT 2021 ROME FOUNDATION. ALL RIGHTS RESERVED. | WEBSITE BY PRECISION MARKETING PARTNERS.